Fjarde Ap-fonden’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.14M Buy
25,497
+1,200
+5% +$315K 0.03% 370
2026
Q1
$6.48M Buy
24,297
+8,750
+56% +$2.37M 0.04% 380
2025
Q4
$3.9M Buy
15,547
+1,840
+13% +$489K 0.03% 378
2025
Q3
$3.94M Buy
13,707
+1,200
+10% +$322K 0.03% 363
2025
Q2
$3.28M Buy
12,507
+100
+0.8% +$24.4K 0.03% 401
2025
Q1
$2.89M Sell
12,407
-200
-2% -$48.5K 0.03% 396
2024
Q4
$2.89M Buy
12,607
+2,900
+30% +$665K 0.03% 434
2024
Q3
$2.17M Buy
+9,707
New +$2.13M 0.02% 465
2024
Q1
$1.71M Sell
7,807
-3,200
-29% -$705K 0.02% 505
2023
Q4
$2.5M Buy
11,007
+6,400
+139% +$1.34M 0.03% 470
2023
Q3
$926K Sell
4,607
-3,316
-42% -$699K 0.01% 524
2023
Q2
$1.64M Sell
7,923
-17,251
-69% -$3.35M 0.02% 504
2023
Q1
$4.96M Buy
25,174
+1,789
+8% +$368K 0.07% 307
2022
Q4
$4.73M Sell
23,385
-8,866
-27% -$1.73M 0.07% 315
2022
Q3
$6.49M Hold
32,251
0.08% 255
2022
Q2
$6.49M Sell
32,251
-2,561
-7% -$546K 0.08% 255
2022
Q1
$7.88M Sell
34,812
-582
-2% -$137K 0.08% 272
2021
Q4
$9.55M Buy
35,394
+1,584
+5% +$392K 0.08% 246
2021
Q3
$8.18M Sell
33,810
-2,328
-6% -$587K 0.08% 266
2021
Q2
$8.56M Buy
36,138
+582
+2% +$133K 0.08% 265
2021
Q1
$7.79M Buy
35,556
+2,561
+8% +$514K 0.07% 274
2020
Q4
$5.77M Sell
32,995
-116
-0.4% -$20K 0.05% 336
2020
Q3
$5.36M Buy
33,111
+1,862
+6% +$295K 0.06% 315
2020
Q2
$4.46M Sell
31,249
-5,580
-15% -$772K 0.06% 339
2020
Q1
$4M Buy
36,829
+466
+1% +$67.1K 0.06% 299
2019
Q4
$5.29M Buy
36,363
+16,645
+84% +$2.4M 0.06% 315
2019
Q3
$2.85M Sell
19,718
-15,371
-44% -$2.24M 0.04% 462
2019
Q2
$5.21M Sell
35,089
-1,280
-4% -$179K 0.07% 322
2019
Q1
$4.78M Buy
36,369
+5,656
+18% +$697K 0.06% 331
2018
Q4
$3.33M Sell
30,713
-4,307
-12% -$577K 0.06% 333
2018
Q3
$5.22M Sell
35,020
-134
-0.4% -$20.4K 0.08% 279
2018
Q2
$5.42M Buy
35,154
+1,810
+5% +$273K 0.08% 266
2018
Q1
$4.63M Sell
33,344
-914
-3% -$134K 0.07% 305
2017
Q4
$4.7M Buy
34,258
+4,647
+16% +$614K 0.07% 298
2017
Q3
$3.84M Buy
29,611
+603
+2% +$80.4K 0.07% 293
2017
Q2
$3.84M Buy
29,008
+3,904
+16% +$478K 0.08% 282
2017
Q1
$3.09M Sell
25,104
-951
-4% -$113K 0.07% 304
2016
Q4
$2.87M Sell
26,055
-2,436
-9% -$271K 0.07% 330
2016
Q3
$3.37M Buy
28,491
+1,145
+4% +$135K 0.07% 303
2016
Q2
$3.06M Buy
27,346
+616
+2% +$66.3K 0.07% 310
2016
Q1
$2.69M Buy
26,730
+3,372
+14% +$323K 0.06% 357
2015
Q4
$2.48M Buy
23,358
+452
+2% +$46.6K 0.07% 347
2015
Q3
$2.13M Sell
22,906
-2,349
-9% -$243K 0.06% 392
2015
Q2
$2.63M Buy
25,255
+50
+0.2% +$5.21K 0.06% 361
2015
Q1
$2.73M Buy
25,205
+860
+4% +$88.4K 0.06% 377
2014
Q4
$2.26M Sell
24,345
-1,114
-4% -$98.4K 0.05% 464
2014
Q3
$2.23M Sell
25,459
-1,659
-6% -$150K 0.05% 463
2014
Q2
$2.39M Sell
27,118
-2,536
-9% -$220K 0.05% 468
2014
Q1
$2.5M Buy
29,654
+1,043
+4% +$83.2K 0.05% 451
2013
Q4
$2.25M Sell
28,611
-3,333
-10% -$284K 0.05% 482
2013
Q3
$2.72M Sell
31,944
-3,005
-9% -$253K 0.06% 401
2013
Q2
$3.01M Buy
+34,949
New +$2.9M 0.06% 372

Other funds holding LH

Fjarde Ap-fonden's LH Position: Q2 2026 in Review

Fjarde Ap-fonden increased its Labcorp (LH) stake by 4.9% in Q2 2026, buying an estimated $315K and bringing the position to 25,497 shares worth $7.14M. The position accounts for 0.03% of the portfolio, ranked #370.

Fjarde Ap-fonden first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.55M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Fjarde Ap-fonden held 25,497 shares of Labcorp worth $7.14M as of Q2 2026.
  • Fjarde Ap-fonden bought 1,200 Labcorp shares in Q2 2026, an estimated $315K.
  • Labcorp made up 0.03% of Fjarde Ap-fonden's portfolio in Q2 2026, its #370 holding.
  • Fjarde Ap-fonden first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Fjarde Ap-fonden's Labcorp position peaked at $9.55M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.